Comparison of Positive and Negative Gastric Cancer Via Multi-omics Analysis
Overview
Affiliations
This is the first clinical research to systematically expound the difference between gastric cancer (GC) individuals with and GC individuals without from the perspective of multi-omics. This clinical study identified significant genes, microbes, and fecal metabolites, which exhibited nice power for differentiating GC individuals with infection from GC individuals without infection. This study provides a crucial basis for a better understanding of eradication therapy among the GC population.
Peng C, Li X, Li Y, Xu X, Ouyang Y, Li N Biol Sex Differ. 2025; 16(1):15.
PMID: 39985099 PMC: 11846230. DOI: 10.1186/s13293-025-00700-z.
Effect of -induced gastric cancer on gastrointestinal microbiota: a narrative review.
Heidary M, Akrami S, Madanipour T, Shakib N, Mahdizade Ari M, Beig M Front Oncol. 2025; 14:1495596.
PMID: 39868371 PMC: 11757270. DOI: 10.3389/fonc.2024.1495596.
The oncogenic role and prognostic value of PXDN in human stomach adenocarcinoma.
Tian Y, Qiu S, Yang S, Jiang Y, Hu H, Yang C BMC Cancer. 2024; 24(1):1463.
PMID: 39609679 PMC: 11603849. DOI: 10.1186/s12885-024-13097-6.
Zhang D, Zhu Q, Huang X, Zhang B, Zhang J, Qin Y J Cancer Res Clin Oncol. 2024; 150(8):382.
PMID: 39103487 PMC: 11300667. DOI: 10.1007/s00432-024-05870-8.
Zhang H, Shen W, Chen L World J Gastrointest Oncol. 2024; 16(6):2419-2428.
PMID: 38994147 PMC: 11236236. DOI: 10.4251/wjgo.v16.i6.2419.